olivLaw · US equity research
The Vita Coco Company, Inc. COCO
Beverages · SIC 2080 · Vertical: Beverages (SIC 2080)
The Vita Coco Company is a U.S. coconut water brand that has extended its portfolio into plant-based beverages, Private Label and, since July 2026, vertically integrated production through the Copra acquisition. In the third quarter of 2026 the company reported net sales of 244 million USD, up 34 percent, and raised its fiscal 2026 guidance.
At the close of 04 Nov 2026, The Vita Coco Company, Inc. (COCO) stock was 65.47 USD (+9.68% on the day), with market capitalisation 3.7 bn USD, P/E 32.9 on diluted EPS of 1.99 USD over the last 12 months, beta 0.70, 52-week range 41.70–84.02 USD. Latest reported quarter (Q3 2026): revenue of 243.8 m USD (+33.7% YoY), net income of 35.0 m USD (+45.9% YoY), diluted EPS 0.58 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 65.6
- strong (55–70)
- Bollinger (20, 2)
- 53.39 – 63.57
- above the upper band · %B 1.19 · band width 17.4%
- SMA 50 / 200
- 57.30 / 61.86
- mixed trend
- MACD (12, 26, 9)
- 0.68 / 0.10
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | +18.3% | −1.1% | +19.4 pp | — |
| 3 months | +1.0% | −0.5% | +1.4 pp | — |
| 6 months | −4.6% | +4.4% | −9.0 pp | — |
| Year to date | +23.5% | +12.3% | +11.2 pp | — |
| 1 year | +64.2% | +13.5% | +50.6 pp | +1.2% |
| 3 years | +126.3% | +76.4% | +49.9 pp | −35.0% |
| 5 years | +380.3% | +63.7% | +316.7 pp | — |
Price returns, dividends excluded.
Quarterly results
Latest quarter: Q3 2026 · 30 Sept 2026
Quarterly margins
Quarterly statements · USD
| Fiscal year | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 127.3 m | 130.9 m | 168.8 m | 182.3 m | 127.8 m | 179.8 m | 216.2 m | 243.8 m |
| Cost of revenue | 86.0 m | 82.8 m | 107.5 m | 113.6 m | 83.2 m | 108.0 m | 110.8 m | 151.1 m |
| Gross profit | 41.3 m | 48.1 m | 61.3 m | 68.7 m | 44.6 m | 71.8 m | 105.3 m | 92.7 m |
| SG&A | 37.0 m | 28.8 m | 36.1 m | 40.7 m | 34.4 m | 38.2 m | 42.2 m | 47.2 m |
| Operating income | 4.3 m | 19.3 m | 25.1 m | 27.9 m | 10.2 m | 33.6 m | 63.1 m | 45.5 m |
| Depreciation & amortisation | 205.0 k | 202.0 k | 206.0 k ≈ | 228.0 k ≈ | 436.0 k | 476.0 k | 489.0 k ≈ | 1.5 m ≈ |
| Interest expense | 0 | — | — | — | — | — | — | — |
| Pre-tax income | 1.7 m | 24.4 m | 28.2 m | 30.7 m | 9.8 m | 37.4 m | 64.4 m | 43.6 m |
| Income tax | -1.7 m | 5.5 m | 5.3 m | 6.7 m | 4.2 m | 7.0 m | 14.9 m | 8.6 m |
| Net income | 3.4 m | 18.9 m | 22.9 m | 24.0 m | 5.5 m | 30.5 m | 49.5 m | 35.0 m |
| Diluted EPS | 0.06 ≈ | 0.31 | 0.38 | 0.40 | 0.09 ≈ | 0.50 | 0.82 | 0.58 |
| Operating cash flow | 6.9 m | -9.8 m | 21.8 m ≈ | 39.1 m ≈ | -3.9 m | 15.6 m | 80.9 m ≈ | 55.4 m ≈ |
| Capex | 125.0 k | 559.0 k | 949.0 k ≈ | 3.4 m ≈ | 3.2 m | 461.0 k | 151.0 k ≈ | 191.0 k ≈ |
| Share repurchases | 0 | 1.5 m | 8.6 m | 151.0 k | 1.1 m | 11.5 m | 8.5 m | 42.4 m ≈ |
≈ derived quarter (cumulative difference / share-days average)
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Today's P/E sits at the 40 percentile of its own 20-quarter history (min 24.3, median 35.7, max 98.6; quarters with earnings only).
Fiscal years
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 283.9 m | 310.6 m | 379.5 m | 427.8 m | 493.6 m | 516.0 m | 609.8 m |
| Revenue YoY | unavailable | +9.4% | +22.2% | +12.7% | +15.4% | +4.5% | +18.2% |
| Net income | 9.4 m | 32.7 m | 19.0 m | 7.8 m | 46.6 m | 56.0 m | 71.3 m |
| Net income YoY | unavailable | +246.8% | −41.8% | −58.9% | +496.7% | +20.0% | +27.5% |
| Diluted EPS | 0.16 | 0.56 | 0.35 | 0.14 | 0.79 | 0.94 | 1.19 |
| Diluted EPS YoY | unavailable | +250.0% | −37.5% | −60.0% | +464.3% | +19.0% | +26.6% |
| net % | 3.3% | 10.5% | 5.0% | 1.8% | 9.4% | 10.8% | 11.7% |
| Free cash flow | 20.8 m | 32.9 m | -16.7 m | -11.9 m | 106.6 m | 41.9 m | 39.0 m |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 196.9 m USD
- Financial debt
- unavailable USD
- Net debt
- unavailable USD
- Equity
- 331.5 m USD
- Total assets
- 461.3 m USD
- Debt / equity
- unavailable
- Current ratio
- 3.62x
- ROE
- 24.2%
- ROA
- 17.3%
- FCF margin
- 6.4%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Revenue | 310.6 m | 379.5 m | 427.8 m | 493.6 m | 516.0 m | 609.8 m | SEC (XBRL)· 18 Feb 2026verified |
| Cost of revenue | 205.8 m | 266.4 m | 324.4 m | 312.9 m | 317.2 m | 387.2 m | SEC (XBRL)· 18 Feb 2026verified |
| Gross profit | 104.9 m | 113.1 m | 103.4 m | 180.7 m | 198.8 m | 222.6 m | SEC (XBRL)· 18 Feb 2026verified |
| Research & development | 313.0 k | 477.0 k | 541.0 k | 418.0 k | 398.0 k | 399.0 k | SEC (XBRL)· 18 Feb 2026verified |
| SG&A | 74.4 m | 88.6 m | 100.3 m | 124.2 m | 125.0 m | 140.1 m | SEC (XBRL)· 18 Feb 2026verified |
| Operating income | 46.9 m | 24.6 m | 3.1 m | 56.5 m | 73.8 m | 82.5 m | SEC (XBRL)· 18 Feb 2026verified |
| Depreciation & amortisation | 2.1 m | 2.1 m | 1.9 m | 660.0 k | 745.0 k | 1.1 m | SEC (XBRL)· 18 Feb 2026verified |
| EBITDA | 49.0 m ≈ | 26.7 m ≈ | 5.0 m ≈ | 57.2 m ≈ | 74.6 m ≈ | 83.6 m ≈ | SEC (XBRL)· 18 Feb 2026derived |
| Interest expense | 791.0 k | 360.0 k | 258.0 k | 31.0 k | 0 | — | SEC (XBRL)· 26 Feb 2025verified |
| Pre-tax income | 43.6 m | 24.2 m | 10.8 m | 57.9 m | 70.8 m | 93.0 m | SEC (XBRL)· 18 Feb 2026verified |
| Income tax | 10.9 m | 5.2 m | 3.0 m | 11.3 m | 14.8 m | 21.7 m | SEC (XBRL)· 18 Feb 2026verified |
| Net income | 32.7 m | 19.0 m | 7.8 m | 46.6 m | 56.0 m | 71.3 m | SEC (XBRL)· 18 Feb 2026verified |
| Diluted EPS | 0.56 | 0.35 | 0.14 | 0.79 | 0.94 | 1.19 | SEC (XBRL)· 18 Feb 2026verified |
| Weighted average diluted shares | 58.6 m | 54.2 m | 56.1 m | 58.7 m | 59.3 m | 60.0 m | SEC (XBRL)· 18 Feb 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating income + Depreciation & amortisation.
Balance sheet · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Cash | 72.2 m | 28.7 m | 19.6 m | 132.5 m | 164.7 m | 196.9 m | SEC (XBRL)· 18 Feb 2026verified |
| Receivables | 30.5 m | 47.2 m | 43.4 m | 50.1 m | 63.5 m | 81.5 m | SEC (XBRL)· 18 Feb 2026verified |
| Inventories | 32.0 m | 75.4 m | 84.1 m | 50.8 m | 83.6 m | 111.5 m | SEC (XBRL)· 18 Feb 2026verified |
| Current assets | 159.1 m | 173.3 m | 174.9 m | 262.9 m | 341.3 m | 421.4 m | SEC (XBRL)· 18 Feb 2026verified |
| Property, plant & equipment, net | 2.9 m | 2.5 m | 2.1 m | 2.1 m | 2.4 m | 9.3 m | SEC (XBRL)· 18 Feb 2026verified |
| Goodwill | 7.8 m | 7.8 m | 7.8 m | 7.8 m | 7.8 m | 7.8 m | SEC (XBRL)· 18 Feb 2026verified |
| Intangibles (excl. goodwill) | 9.2 m | 7.9 m | 0 | 0 | — | 0 | SEC (XBRL)· 22 Oct 2026verified |
| Total assets | 183.9 m | 197.5 m | 197.8 m | 285.7 m | 362.4 m | 461.3 m | SEC (XBRL)· 22 Oct 2026verified |
| Accounts payable | 15.8 m | 28.3 m | 15.9 m | 21.8 m | 30.8 m | 25.5 m | SEC (XBRL)· 18 Feb 2026verified |
| Current liabilities | 55.7 m | 74.0 m | 54.3 m | 82.6 m | 103.3 m | 116.4 m | SEC (XBRL)· 18 Feb 2026verified |
| Total liabilities | 81.6 m | 74.3 m | 56.7 m | 83.2 m | 103.6 m | 129.8 m | SEC (XBRL)· 22 Oct 2026verified |
| Equity | 102.3 m | 123.2 m | 141.1 m | 202.4 m | 258.8 m † | 331.5 m † | SEC (XBRL)· 18 Feb 2026verified |
† equity attributable to the parent's shareholders: in these years the issuer no longer reports the total including non-controlling interests.
Cash flow · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 33.3 m | -16.2 m | -10.9 m | 107.2 m | 42.9 m | 47.2 m | SEC (XBRL)· 18 Feb 2026verified |
| Capex | 392.0 k | 557.0 k | 982.0 k | 599.0 k | 974.0 k | 8.1 m | SEC (XBRL)· 18 Feb 2026verified |
| Free cash flow | 32.9 m ≈ | -16.7 m ≈ | -11.9 m ≈ | 106.6 m ≈ | 41.9 m ≈ | 39.0 m ≈ | SEC (XBRL)· 18 Feb 2026derived |
| Investing cash flow | -375.0 k | -557.0 k | -982.0 k | -594.0 k | -974.0 k | -8.3 m | SEC (XBRL)· 18 Feb 2026verified |
| Financing cash flow | 2.1 m | -26.8 m | 3.0 m | 6.3 m | -8.3 m | -7.5 m | SEC (XBRL)· 18 Feb 2026verified |
| Share repurchases | 6.9 m | 50.0 m | 0 | 773.0 k | 12.0 m | 11.3 m | SEC (XBRL)· 18 Feb 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
- score weight coverage: 58.3% of at least 60%
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 3.7 bn USD
Key indicators
Coverage and freshness
Score by group
58% · Insufficient data
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 38.01 – 65.52 USD.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (USD per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)unavailable · the reported interest expense is far older than the latest period (the filer changed its XBRL tag): a stale figure is not used
- Peers: EV/EBITDAunavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
- Peers: P/E38.01 – 65.52 (Mid 48.34)6 companies used · median multiple 24.3x · quartiles 19.1x – 32.9xBF-A, BUDA, KDP, KO, PEP, YHC
- Dividend discount (DDM)unavailable · the company pays no dividend: a dividend model needs an explicit initiation assumption
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Insufficient data
Minimum-evidence gate: score weight coverage: 58.3% of at least 60%
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | unavailable | unavailable | — |
| Net margin · Quality | 15.7% | 71 (vs peers) | 11% |
| FCF conversion · Quality | 119.5% | 100 (on a fixed band) | 11% |
| Revenue CAGR 3Y · Growth | 12.5% | 100 (on a fixed band) | 14% |
| EPS CAGR 3Y · Growth | 104.1% | 100 (on a fixed band) | 14% |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | unavailable | unavailable | — |
| Current ratio · Balance sheet | 2.5x | 100 (on a fixed band) | 7% |
| P/E (TTM) · Valuation | 32.9x | 50 (vs peers) | 18% |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | 3.9% | 48 (on a fixed band) | 14% |
| Shareholder yield (distributions) · Returns | 1.7% | 24 (on a fixed band) | 11% |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet· partial100/100 · 1/3 factors with a value
- Growth100/100 · 2/2 factors with a value
- Quality85/100 · 2/3 factors with a value
- Returns· partial24/100 · 1/2 factors with a value
- Valuation49/100 · 2/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
The Vita Coco Company, Inc. (COCO). Latest full fiscal year: 2025; data up to 2026-09-30.
Figures computed from the financial statements: revenue 609.8 m USD in 2025; YoY growth 18.2%; net margin 15.7%; ROE 32.0%.
The estimated value range is 38.01–65.52 USD per share (median of 1 methods, agreement: single method); assumptions are illustrative. Against the central value of 48.34 USD, the price of 65.47 USD leaves a potential of -26.2% (value / price − 1) and a margin of safety of -35.4% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
Insufficient data for a verdict (score weight coverage: 58.3% of at least 60%).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- Net margin: 15.7%
- FCF conversion: 119.5%
- Revenue CAGR 3Y: 12.5%
- EPS CAGR 3Y: 104.1%
- Current ratio: 2.5x
What contradicts it
- Shareholder yield (distributions): 1.7%
Not assessed (insufficient data or a ratio without meaning): ROIC, Net debt / EBITDA, Interest coverage, EV/EBITDA, Payout ratio (FCF).
Versus the vertical median
Beverages (SIC 2080) · same industry (4-digit SIC) · compared with 17 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| KOCoca Cola Co | 412.1 bn | 28.2 | 42.6% | 28.7% | +1.9% | +31% / +64% |
| DEODIAGEO plc | 237.6 bn | 92.4 | 24.0% | 9.1% | +0.3% | +7% / −30% |
| PEPPepsico Inc | 194.1 bn | 18.7 | 50.1% | 10.8% | +2.3% | −4% / −15% |
| KDPKeurig Dr Pepper Inc. | 50.1 bn | 37.2 | 5.7% | 7.1% | +8.2% | +32% / +17% |
| BF-ABrown Forman Corp | 14.9 bn | 20.3 | 18.1% | 18.4% | −1.2% | +10% / −48% |
| PRMBPrimo Brands Corp | 7.6 bn | 79.4 | 3.2% | 1.5% | +29.3% | +34% / +46% |
| COCOThe Vita Coco Company, Inc. | 3.7 bn | 32.9 | 32.0% | 15.7% | +18.2% | +64% / +126% |
| WESTWestrock Coffee Company | 1.0 bn | — | — | -4.9% | +39.8% | +138% / +13% |
| BUDABuda Juice, Inc. | 83.2 m | 34.5 | 19.3% | 17.1% | +11.8% | unavailable / unavailable |
| SRXHSRX Global Inc. | 18.0 m | — | -70.8% | -254.8% | −81.3% | −96% / −100% |
| WVVIWillamette Valley Vineyards, Inc. | 8.3 m | — | -3.3% | -5.9% | −6.5% | −37% / −68% |
| YHCLQR House Inc. | 2.9 m | 0.2 | -88.2% | -1,589.2% | −37.4% | −98% / −100% |
| IPSTIp Strategy Holdings, Inc. | 2.3 m | — | -2,713.2% | -2,064.0% | +20.4% | −98% / unavailable |
| EDVAEndovia Health Sciences, Inc. | 1.2 m | — | — | -53,856.5% | −90.9% | −96% / −100% |
| BRCCBRC Inc. | 903.4 k | — | -14.2% | -1.5% | +1.7% | −23% / −77% |
| IBGInnovation Beverage Group Limited | 593.4 k | — | — | -223.4% | −5.1% | −94% / unavailable |
| ABEVAmbev S.A. | — | — | 16.6% | 17.6% | −1.4% | +9% / +1% |
| STZConstellation Brands, Inc. | — | — | 23.9% | 20.9% | −10.5% | +7% / −40% |
1- and 3-year price returns: for COCO from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | 44.34 Total return -32% · Per year -32% | 78.11 Total return 19% · Per year 19% | 117.26 Total return 79% · Per year 79% |
| 3 years | 50.27 Total return -23% · Per year -8% | 98.93 Total return 51% · Per year 15% | 162.01 Total return 147% · Per year 35% |
| 5 years | 56.99 Total return -13% · Per year -3% | 125.30 Total return 91% · Per year 14% | 223.84 Total return 242% · Per year 28% |
- Exit P/E± 24.73
- Net margin± 17.31
- Annual revenue growth± 13.19
- Annual dilution± 1.45
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
In brief
The Vita Coco Company is a U.S. coconut water brand that has extended its portfolio into plant-based beverages, Private Label and, since July 2026, vertically integrated production through the Copra acquisition. In the third quarter of 2026 the company reported net sales of 244 million USD, up 34 percent, and raised its fiscal 2026 guidance.
SWOT
Strengths
Weaknesses
- Dependence on coconut water is very high, and this category accounts for nearly all revenue 1.
- The company relies on a small number of large customers and Private Label contracts that can be lost or reallocated quickly 1.
- Gross margin is sensitive to transport costs and product mix, and Copra diluted margin in the third quarter 3.
Opportunities
- Europe and Asia offer growth potential for coconut water, and Copra opens access to the super-premium segment 3.
- The functional beverage market is far larger than the current category, which could support portfolio diversification 1.
- Integrating Thai production could reduce reliance on third parties and improve quality control 2.
Risks
- Concentration on coconut waterhigh
Nearly all revenue comes from one category, so a fall in demand would have a large effect on results 1.
- Loss of large customershigh
Private Label contracts are rebid regularly and changes can come abruptly, which could reduce sales 1.
- Transport costs and tariffsmedium
Rising ocean freight and new tariffs could compress gross margin, especially if prices cannot be passed on 2.
- Copra integrationmedium
The acquisition adds integration and amortization costs, and synergies could take longer than expected 3.
- Supply chainmedium
Coconut harvests are exposed to weather and natural disasters, which could reduce raw material availability 1.
Investment thesis
What would need to be true (bull case)
- If organic growth remains strong and guidance is met, the company could show that profitability can grow on a durable basis 3.
- Its leading position in the U.S. and U.K. gives a brand advantage, and expansion in Europe and Asia could add volume 13.
- The Copra acquisition could create a super-premium segment and better vertical integration, which could improve cost control 2.
What would break the thesis
- If demand for coconut water slows, results could be hit hard given how concentrated revenue is 1.
- Tariff refund gains are one-off, and without them gross margin could be lower than the level reported in 2026 2.
- Competition from large brands and retailer Private Label could limit the ability to raise prices 1.
What to watch
- Organic sales growth trend after CopraQ4 2026
- Effect of Copra integration on SG&A and amortization2027
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
The business
The company pioneered packaged coconut water in 2004 and operates as a functional beverage brand, led by Vita Coco, with coconut oil, juice, coconut milk, PWR LIFT and, from 2026, Copra products 12. A significant part of the business is supplying coconut water under Private Label to leading retailers. The supply model is largely asset-light, with about 16 partner factories across six countries 1. The company is a Delaware public benefit corporation that completed its IPO in October 2021 1.
The company runs two segments: Americas, covering the U.S. and Canada, and International, covering Europe, the Middle East, Africa and Asia Pacific 1. Its strategy focuses on expanding the coconut water category, growing distribution of new products and developing international markets, including the Coco Ventures joint venture in China 1.
Segments
Private Label
The Private Label segment supplies coconut water and coconut oil to retailers and has been the fastest-growing area recently. Sales rose 152 percent in the third quarter of 2026, partly reflecting the Copra contribution 2. Contracts are rebid regularly, which can make revenue harder to forecast 1.
Market context
The global coconut water and plant water market is among the faster-growing beverage categories, and the company considers itself one of the largest brands in it 1. Consumption of natural beverages is rising, driven by interest in hydration and products with fewer sugars and additives 1. The company reported that demand in Europe and America remained solid, with more households buying the product 3.
The functional beverage market is significantly larger than the coconut water category, which leaves room for expansion 1. Price pressure is high, however, and the products are price-sensitive, limiting the ability to pass cost increases to customers 1.
Trends
- Demand for coconut watertailwind
The coconut water category has grown steadily, and growth in 2026 was supported by solid demand in all major markets 3. If this momentum holds, it could support continued growth in the core line.
- Tariffs and transport costsmixed
Tariffs in 2025 raised import costs, and the Supreme Court ruled certain IEEPA tariffs unlawful, enabling refunds 2. Newly announced measures could, however, compress margins again if applied.
- Ocean freight costsheadwind
Ocean freight costs have been volatile and have materially affected financial results in recent years, and because of price sensitivity the company may not be able to pass these increases to customers 1. This can weigh on gross margin.
- Consolidation through acquisitionmixed
The July 2026 Copra acquisition extends access to super-premium Nam Hom coconut water and production capacity in Thailand 2. Integration may bring benefits but also costs and margin dilution, as the company noted 3.
Competitive position
The company competes in the non-alcoholic beverage category with sports drinks, energy drinks, enhanced waters and other functional beverages, and its large competitors include The Coca-Cola Company, PepsiCo and Nestlé 1. In U.S. coconut water it competes with Goya, Harmless Harvest, Zico and C20, as well as emerging brands and retailer Private Label brands 1.
Competition is based on brand recognition, taste, quality, price, availability and sustainability factors 1. In Private Label the company competes with other suppliers for contracts that are rebid regularly, so its position can shift quickly 1.
- The Coca-Cola CompanyKO
Large beverage company named as a competitor in non-alcoholic beverages, with greater financial resources and brand recognition 1.
- PepsiCo, Inc.PEP
Large beverage and food company named as a competitor with greater financial resources 1.
- Nestlé S.A.
International food and beverage group named as a competitor in beverages 1.
- Goya, Harmless Harvest, Zico, C20
Coconut water brands competing in the U.S. market, without a confirmed U.S. listing in the source 1.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
No news in our archive over the last 180 days.
SEC filings
- Quarterly report22 Oct 2026
- Current report22 Oct 2026Results of operations · Financial statements and exhibits
- Quarterly report23 Jul 2026
- Current report23 Jul 2026Results of operations · Financial statements and exhibits
- Current report22 Jul 2026Material agreement · Acquisition or disposition of assets · Item 3.02 · Regulation FD disclosure · Financial statements and exhibits
- Current report04 Jun 2026Shareholder vote
- Quarterly report29 Apr 2026
- Current report29 Apr 2026Results of operations · Financial statements and exhibits
- Current report (amendment)22 Apr 2026Departure or appointment of officers
- Proxy statement22 Apr 2026
Sources
- [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / The Vita Coco Company, Inc. · 18 Feb 2026
- [2] Form 10-Q, quarter ended 2026-09-30 · SEC / The Vita Coco Company, Inc. · 22 Oct 2026
- [3] Form 8-K, results release (exhibit 99.1) · SEC / The Vita Coco Company, Inc. · 22 Oct 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.